All In Biotech

Drug Trial Radar · NCT06095128

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

An Open-Label, Phase 4, Single-Arm, Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy With Tofacitinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jun 12, 2024

Primary completion

Jul 9, 2027

Study completion Jul 9, 2027

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Oct 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with vedolizumab alone after the double treatment. All participants will receive vedolizumab together with tofacitinib for 8 weeks and will be checked for response. Participants who show a response to the treatment after 8 weeks will be treated with vedolizumab alone for an additional 44 weeks. Each participant will be followed up for at least 26 weeks after the last dose of vedolizumab.

Conditions

  • Ulcerative Colitis

Interventions

  • VedolizumabDrug

    Vedolizumab IV infusions

  • TofacitinibDrug

    Tofacitinib Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Clinical Remission at Week 8 Based on Complete Mayo ScoreTime frame: At Week 8

Locations

45 sites in 2 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialsits

    Dothan, Alabama

  • GI Alliance Sun City

    Sun City, Arizona

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • Hoag Hospital Newport Beach

    Newport Beach, California

  • Endoscopic Research Inc

    Orlando, Florida

  • Alliance Clinical Research of Tampa, LLC

    Tampa, Florida

  • Gastroenterology Consultants, P.C.

    Roswell, Georgia

  • University of Chicago Medicine

    Chicago, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • University of Louisville

    Louisville, Kentucky

  • GI Alliance

    Metairie, Louisiana

  • Tulane University

    New Orleans, Louisiana

  • Capital Digestive Care - MGG Group - Chevy Chase Clinical Research

    Chevy Chase, Maryland

  • Huron Gastroenterology Associates, P.C.

    Ypsilanti, Michigan

  • MNGI Digestive Health, PA

    Plymouth, Minnesota

  • Mid-America Gastro-Intestinal Consultants

    Kansas City, Missouri

  • BVL Clinical Research

    Liberty, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • NYU Langone Health

    New York, New York

  • Weill Cornell Medical College- New York Presbyterian Hospital

    New York, New York

  • Digestive Health Partners

    Asheville, North Carolina

  • University of North Carolina

    Chapel Hill, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Ohio Gastroenterology group, Inc.

    Columbus, Ohio

  • Gastro Intestinal Research Institute of Northern Ohio, LLC.

    Westlake, Ohio

  • Allegheny Health Network

    Wexford, Pennsylvania

  • University Gastroenterology

    Providence, Rhode Island

  • Sanford Health Research

    Rapid City, South Dakota

  • The University of Texas Health Science Center at Houston

    Houston, Texas

  • GI Alliance - Mansfield

    Mansfield, Texas

  • Gastroenterology Research of San Antonio, LLC

    San Antonio, Texas

  • Texas Digestive Disease Consultants (TDDC), Southlake

    Southlake, Texas

  • Tyler Research Institute, LLC

    Tyler, Texas

  • GI Alliance - Webster

    Webster, Texas

  • University of Utah Health

    Salt Lake City, Utah

  • Washington Gastroenterology- GIA

    Tacoma, Washington

  • Barrie GI Associates Inc.

    Barrie, Ontario, Canada

  • London Health Sciences Centre

    London, Ontario, Canada

  • West GTA Endoscopy Inc.

    Mississauga, Ontario, Canada

  • Viable Clinical Research - North Bay

    North Bay, Ontario, Canada

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.